CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.51B
AUM Growth
-$1.02B
(-13%)
Cap. Flow
+$50.5M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
900
New
86
Increased
331
Reduced
275
Closed
84
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$52.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$29.4M |
| 3 |
Biogen
BIIB
|
$18.6M |
| 4 |
Mastercard
MA
|
$17.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
$17.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$50.7M |
| 2 |
Ecopetrol
EC
|
$21.5M |
| 3 |
AET
Aetna Inc
AET
|
$20.2M |
| 4 |
Amgen
AMGN
|
$19.2M |
| 5 |
Merck
MRK
|
$18.5M |
Sector Composition
| 1 | Healthcare | 35.32% |
| 2 | Technology | 15.37% |
| 3 | Financials | 11.61% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Prudential Financial
PRU
$38.2B
| $18.2M | 0.28% |
223,665
-13,520
| -6% | -$1.1M |
|
77
NVIDIA
NVDA
$4.15T
| $18.1M | 0.28% |
5,414,320
+842,120
| +18% | +$2.81M |
|
78
Arista Networks
ANET
$177B
| $17.8M | 0.27% |
1,353,136
-135,600
| -9% | -$1.79M |
|
79
Intuit
INTU
$186B
| $17.3M | 0.27% |
88,006
+29,481
| +50% | +$5.8M |
|
|
AERI
80
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $17.3M | 0.27% |
478,800
+152,000
| +47% | +$5.49M |
|
81
3M
MMM
$81.5B
| $17.2M | 0.26% |
107,976
+12,662
| +13% | +$2.02M |
|
82
Eli Lilly
LLY
$668B
| $17.1M | 0.26% |
147,702
-14,379
| -9% | -$1.66M |
|
83
TJX Companies
TJX
$157B
| $16.9M | 0.26% |
378,251
+64,751
| +21% | +$2.9M |
|
84
MetLife
MET
$54.3B
| $16.9M | 0.26% |
411,929
-9,502
| -2% | -$390K |
|
85
Air Products & Chemicals
APD
$64.5B
| $16.9M | 0.26% |
105,338
+10,049
| +11% | +$1.61M |
|
86
Karyopharm Therapeutics
KPTI
$59.6M
| $16.8M | 0.26% |
119,503
+47,136
| +65% | +$6.62M |
|
|
BLUE
87
DELISTED
bluebird bio
BLUE
| $16.8M | 0.26% |
13,055
+5,057
| +63% | +$6.5M |
|
88
GE Aerospace
GE
$298B
| $16.5M | 0.25% |
455,380
+7,648
| +2% | +$277K |
|
89
Neurocrine Biosciences
NBIX
$13.7B
| $16.3M | 0.25% |
228,069
+78,000
| +52% | +$5.57M |
|
90
FibroGen
FGEN
$47.2M
| $16.2M | 0.25% |
14,036
-2,400
| -15% | -$2.78M |
|
|
RARX
91
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $16M | 0.25% |
879,000
+444,000
| +102% | +$8.08M |
|
92
DuPont de Nemours
DD
$32.1B
| $16M | 0.25% |
147,914
+26,513
| +22% | +$2.86M |
|
93
PACCAR
PCAR
$51.1B
| $15.9M | 0.24% |
418,257
-924
| -0.2% | -$35.2K |
|
94
Palo Alto Networks
PANW
$130B
| $15.8M | 0.24% |
502,458
-198
| -0% | -$6.22K |
|
95
ConocoPhillips
COP
$120B
| $15.7M | 0.24% |
252,488
-165,508
| -40% | -$10.3M |
|
96
Bank of America
BAC
$375B
| $15.5M | 0.24% |
628,104
+194,165
| +45% | +$4.78M |
|
97
Colgate-Palmolive
CL
$67.5B
| $15.4M | 0.24% |
259,494
+14,727
| +6% | +$877K |
|
98
Coca-Cola
KO
$295B
| $15.4M | 0.24% |
324,861
-67,782
| -17% | -$3.21M |
|
99
Baidu
BIDU
$33.7B
| $15.4M | 0.24% |
96,874
-3,244
| -3% | -$514K |
|
|
SAGE
100
DELISTED
Sage Therapeutics
SAGE
| $15.4M | 0.24% |
160,300
+22,500
| +16% | +$2.16M |
|